www.aasraw.com

AASraw offers small-scale production capabilities to quickly respond to the demand for smaller quantities and scale-up development needs (1 to 50 kg).

AASraw's facilities are suited to the manufacturing of chemical intermediates and active pharmaceutical ingredients (APIs) in clinical trials,

as well as for marketed small-volume APIs. The small-scale plants operate according to GMP guidelines.